Treatment of Males with Low Testosterone
JE · Effective Jul 12, 2016
12 active Medicare policies list J3121, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Jul 12, 2016
JF · Effective Jul 12, 2016
JJ · Effective Feb 13, 2022
JM · Effective Feb 13, 2022
J9 · Effective Oct 1, 2015
J9
JH · Effective Oct 1, 2015
JH
JL · Effective Oct 1, 2015
JL
9 policies from 9 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J3121 |
|---|---|---|
| Alzheimer's Disease: Experimental, Investigational, or Unproven Treatments | Feb 20, 2024 | Covered |
| Policy | Effective | Status of J3121 |
|---|---|---|
| Gender Assignment Surgery and Gender Reassignment Surgery with Related Services | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J3121 |
|---|---|---|
| Gender Assignment Surgery and Gender Reassignment Surgery with Related Services |
National · Effective Oct 16, 2025
National · Effective Apr 2, 2026
| Jan 1, 2026 |
| Covered |
| Policy | Effective | Status of J3121 |
|---|---|---|
| Gender Assignment Surgery and Gender Reassignment Surgery with Related Services | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J3121 |
|---|---|---|
| Gender Assignment Surgery and Gender Reassignment Surgery with Related Services | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J3121 |
|---|---|---|
| Testosterone [Implantable Testosterone Pellets (Testopel Pellets), Testosterone Undecanoate (Aveed)], Testosterone Cypionate (Depo-Testosterone), or Testosterone Enanthate (Delatestryl)] | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3121 |
|---|---|---|
| Testosterone Replacement or Supplementation Therapy | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J3121 |
|---|---|---|
| Testosterone Replacement or Supplementation Therapy | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J3121 |
|---|---|---|
| Testosterone Replacement or Supplementation Therapy | Jan 1, 2026 | Covered |